Oragenics Inc
OGEN· NYSE
OGENOragenics Inc
Filed Aug 5, 2011 · 10-Q · 36 days after period end · 0001193125-11-212288
| Metric | Q2 2011 | Q2 2010 |
|---|---|---|
| Revenue | $347.57K | $304.70K |
| Net Income | -$2.37M | -$2.01M |
| EPS Diluted | -$0.42 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Oragenics Inc · CIK 1174940 · Engraved from SEC EDGAR
ended Jun 30, 2011 · filed Aug 5, 2011 · 36 d after period end
